07:00 , Oct 26, 2015 |  BC Week In Review  |  Financial News

Humacyte completes venture financing

Humacyte Inc. , Research Triangle Park, N.C.   Business: Cardiovascular, Dermatology   Date completed: 2015-10-20   Type: Venture financing   Raised: Not disclosed   Investors: Access Industries Inc.; Bangkok Bank; Pacific Eagle Asset Management; Reignwood...
07:00 , Oct 5, 2015 |  BioCentury  |  Finance

Lighting up neoantigens

Investors led by Third Rock Ventures put $55 million into Neon Therapeutics Inc. to exploit recently discovered neoantigen biology from the Broad Institute of MIT and Harvard and Dana-Farber Cancer Institute . Neon will develop...
07:00 , Oct 5, 2015 |  BC Week In Review  |  Financial News

Neon Therapeutics Inc. completes venture financing

Neon Therapeutics Inc. , Cambridge, Mass.   Business: Cancer   Date completed: 2015-10-01   Type: Venture financing   Raised: $55 million   Investors: Third Rock Ventures; Clal Biotechnology Industries; Access Industries Inc.  ...
08:00 , Mar 4, 2013 |  BioCentury  |  Emerging Company Profile

Vedantra: Boosting T cell responses

Vedantra Pharmaceuticals Inc. is developing nanoparticle vaccines that are designed to generate a more potent antibody and T cell response than traditional subunit vaccines. By delivering antigens and immunostimulatory adjuvants in multilayer lipid vesicles, the...
08:00 , Jan 2, 2012 |  BC Week In Review  |  Financial News

Access Industries Inc. financial update

Industrial holdings firm Access Industries Inc. launched Access BridgeGap Ventures, a venture investment initiative to fund early stage life science companies on the North Atlantic seaboard. The arm will deploy $75 million over the next...
08:00 , Jan 2, 2012 |  BioCentury  |  Finance

Into the gap

Into the gap At least one new VC thinks the time is ripe to address the tech transfer funding gap. Diversified multinational...
02:16 , Dec 20, 2011 |  BC Extra  |  Financial News

Access Industries launches life science investment arm

Industrial holdings firm Access Industries Inc. launched Access BridgeGap Ventures, a venture investment initiative to fund early stage life science companies on the North Atlantic seaboard. The arm will deploy $75 million over the next...